Mesa Verde Venture Partners

The Mesa Verde team consists of three Managing Directors and a group of Advisors and Partners who have successfully built and invested in early-stage companies in the life sciences space

Mesa Verde invests in a diversified portfolio of companies across the life sciences space Our portfolio companies are developing and commercializing products that improve human health and provide superior returns for our investors

Acquired by Exact Sciences Acquired by Bionano Genomics Acquired by Nabriva Therapeutics Oncternal Provides Business Update and Announces First Quarter 2021 Financial Results Nabriva Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Updates Equillium Announces Three Abstracts Accepted for Presentation at the 104th AAI Annual Meeting 4225 Executive Square Suite 600 La Jolla, CA 92037 4225 Executive Square Suite 600 La Jolla, CA 92037